SAFP CPD Program: CPD Article

The Human Genome and Gene “Therapy”: Some Ethical Issues

D. Knapp van Bogaert, G.A. Ogunbanjo
South African Family Practice | Vol 51, No 6 : November/December| a1512 | DOI: https://doi.org/10.1080/20786204.2009.10873907 | ©
Submitted: 22 December 2009 | Published: 30 December 2009

About the author(s)

D. Knapp van Bogaert, University of the Witwatersrand, South Africa
G.A. Ogunbanjo, University of Limpopo, South Africa

Full Text:

PDF (640KB)

Abstract

The major scientific achievement of the Twentieth Century was the discovery of the double helix, and the mapping of the human genome in 2003. Contemporary medical and scientific knowledge in the field of gene therapy has the potential to inform us about many of the known inherited genetic conditions. In addition, medicine now has the ability to identify a significant number of diseases which may be inherited from us by our children. When we discuss the ethics of gene therapy, a distinction should be made between somatic (non-reproductive) and germ (reproductive) cell therapies. In this article, we focus on the ethical issues related to prenatal screening for genetic disorders which include autonomy, cost and maternal anxiety.

Keywords

human genome; gene therapy; ethical issues

Metrics

Total abstract views: 1756
Total article views: 2513


Crossref Citations

No related citations found.